Market Currents
Oncothyreon (ONTY +16%) is higher today on a rumor that Phase III results of its cancer...
-
Wednesday, July 20, 2011, 2:45 PM ETOncothyreon (ONTY +16%) is higher today on a rumor that Phase III results of its cancer treatment drug Stimuvax are meeting endpoints. The stock has been heavily shorted recently - short interest now averages 2+ days to cover - adding to the stock's volatility.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
